Aemetis (NASDAQ:AMTX) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Aemetis, Inc. (NASDAQ:AMTX)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.66 and traded as low as $1.91. Aemetis shares last traded at $1.94, with a volume of 566,085 shares traded.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. StockNews.com upgraded Aemetis to a “sell” rating in a research note on Wednesday, February 5th. Ascendiant Capital Markets raised their target price on shares of Aemetis from $18.00 to $19.00 and gave the company a “buy” rating in a report on Monday, March 17th. Finally, HC Wainwright reissued a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research report on Friday, March 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Aemetis currently has a consensus rating of “Hold” and an average price target of $14.56.

Aemetis Price Performance

The firm has a 50 day moving average of $2.06 and a two-hundred day moving average of $2.66. The stock has a market cap of $103.44 million, a PE ratio of -0.86 and a beta of 1.48.

Institutional Trading of Aemetis

Institutional investors have recently modified their holdings of the stock. FMR LLC increased its position in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares in the last quarter. State Street Corp grew its stake in Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares during the last quarter. Wellington Management Group LLP acquired a new position in Aemetis during the third quarter worth approximately $177,000. Barclays PLC lifted its stake in Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after buying an additional 34,816 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after acquiring an additional 66,031 shares during the period. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.